Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients
Status: AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Triple Negative Local Advanced Breast Cancer
Interventions: DRUG: docetaxel oxaliplatin
Sponsor: Fudan University
Collaborators: Chinese Anti-Cancer Association